Hyperparathyroidism And Stroke: Mayo Clinic's Insights

Hyperparathyroidism is a condition that affects the parathyroid glands and the hormone they produce. It can be caused by growths or enlarged glands, or by kidney disease or low calcium levels. This can lead to high levels of calcium in the blood, also known as hypercalcemia, which can cause a variety of persistent symptoms and health problems, including osteoporosis and kidney stones. Left untreated, hypercalcemia can also lead to more serious complications such as a heart attack, high blood pressure, or stroke.

Hyperparathyroidism can cause hypercalcemia

Hyperparathyroidism is a condition that affects the parathyroid glands and the hormone they produce. The human body usually has four parathyroid glands, each about the size of a grain of rice, located near the thyroid gland in the neck. These glands produce parathyroid hormone (PTH), which plays a crucial role in regulating the body's blood levels of calcium and phosphorus.

When the parathyroid glands produce excessive amounts of PTH, it leads to a condition called primary hyperparathyroidism. This can occur due to an enlargement of one or more of the parathyroid glands, resulting in the overproduction of PTH. Consequently, high levels of PTH cause an increase in calcium levels in the blood, a condition known as hypercalcemia.

Hypercalcemia can have various adverse effects on the body. Firstly, it interferes with the functions of nerves, muscles, the heart, and blood vessels, as calcium is essential for their proper functioning. Additionally, hypercalcemia can lead to osteoporosis, a bone-thinning disease. This occurs when the bones continue to release calcium into the blood, causing a decrease in bone density. Moreover, hypercalcemia can result in the formation of kidney stones. When there is too much calcium in the urine, crystals may form in the kidneys, leading to kidney stones over time.

The symptoms of hypercalcemia include fatigue, aches and pains in the muscles and joints, and problems with concentration or memory. Left untreated, hypercalcemia can lead to persistent symptoms and serious health complications. Treatment options for hypercalcemia caused by primary hyperparathyroidism include surgery, medication, and monitoring. Surgery involves removing the affected parathyroid gland(s), and it is typically recommended when hypercalcemia becomes severe or uncontrollable. Medications such as calcimimetics may be prescribed to trick the parathyroid glands into releasing less PTH. In some cases, mild hypercalcemia may be monitored through regular blood tests without immediate treatment.

High calcium levels can lead to osteoporosis

The parathyroid glands play a crucial role in maintaining the body's calcium levels. When these glands malfunction, it can lead to hyperparathyroidism, which results in elevated calcium levels in the blood. This condition can have adverse effects on various bodily functions, including bone health.

Osteoporosis is a disease characterised by weak and brittle bones. It occurs when the body fails to form enough new bone or when too much existing bone is absorbed by the body. While several factors contribute to osteoporosis, high calcium levels in the blood, known as hypercalcemia, can be a significant contributor.

The parathyroid glands regulate calcium levels in the bones and blood by producing parathyroid hormone (PTH). When these glands are overactive, they release excessive PTH, which triggers the release of calcium from the bones into the bloodstream. As a result, bones lose their calcium content, becoming weaker and more susceptible to fractures—the hallmark of osteoporosis.

The link between hyperparathyroidism and osteoporosis is well-established. In a study from southern Sweden, patients with elevated calcium levels at the baseline had a higher prevalence of osteoporosis ten years later compared to those with normal calcium levels (45% vs. 29%). This finding underscores the importance of further evaluation, even when parathyroid hormone levels appear normal.

Additionally, hyperparathyroidism can lead to secondary osteoporosis. Treatment for hyperparathyroidism often involves surgery to remove the affected parathyroid gland(s). However, in cases where surgery is not recommended or as a pre-surgical measure, medication such as bisphosphonates may be prescribed to slow down bone loss and reduce the risk of osteoporosis.

In summary, high calcium levels resulting from hyperparathyroidism can disrupt the body's calcium balance and contribute to the development of osteoporosis. Early detection, proper diagnosis, and timely treatment of hyperparathyroidism are crucial to mitigate the risk of osteoporosis and other associated health complications.

Kidney stones may form due to excess calcium in urine

Hyperparathyroidism is a condition that affects the parathyroid glands and the hormone they produce. In most cases, it is caused by an enlarged parathyroid gland that releases too much parathyroid hormone (PTH). PTH controls the level of calcium in the blood. When the parathyroid glands produce too much PTH, it can lead to excess calcium in the blood, a condition known as hypercalcemia.

Hypercalcemia can cause various health problems, including osteoporosis and kidney stones. If left untreated, hypercalcemia can lead to serious complications. For example, if the urine contains too much calcium, crystals may form in the kidneys, which can then combine to form kidney stones.

Kidney stones are hard objects made up of tiny crystals that form on the interior surface of the kidney. The kidneys maintain the body's balance of water, minerals, and salts, and urine is the product of this filtering process. When substances like calcium, oxalate, and phosphate become too concentrated in the urine, they can separate out as crystals. Kidney stones develop when these crystals attach to each other, forming a small mass or stone.

Calcium stones are the most common type of kidney stone, with 80% being calcium oxalate and the rest being calcium phosphate. People with hyperparathyroidism may have excess calcium in their urine, increasing their risk of calcium kidney stones. However, it is important to note that high urine calcium levels may not always be due to a high calcium intake. It can also be caused by the body's handling of calcium or the absorption of calcium from the intestines or bones.

To prevent kidney stones, it is recommended to increase fluid intake to dilute the urine and reduce the concentration of crystals. Additionally, reducing sodium intake can help lower urine calcium levels, as excess sodium in the urine prevents calcium from being reabsorbed into the blood. While dietary calcium restriction is not typically recommended, it is important to ensure calcium intake is not too high.

Primary hyperparathyroidism is caused by growths or enlarged glands

Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood, known as hypercalcemia. There are two types of hyperparathyroidism: primary and secondary.

When the parathyroid glands become enlarged or affected by growths, they can release too much PTH. This leads to an increase in calcium levels in the blood, as PTH triggers the release of calcium from the bones. Primary hyperparathyroidism can cause various health problems, including osteoporosis, kidney stones, and cardiovascular issues.

The most common treatment for primary hyperparathyroidism is surgery to remove the affected gland(s). This procedure, known as a parathyroidectomy, is typically very effective at curing the condition and restoring normal calcium levels. In cases where surgery is not an option, medication such as calcimimetics may be prescribed to manage the condition.

Secondary hyperparathyroidism is caused by kidney disease or low calcium levels

Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH). This can cause high levels of calcium in the blood, known as hypercalcemia. There are two types of hyperparathyroidism: primary and secondary.

Secondary hyperparathyroidism occurs when the body first experiences low calcium levels, causing the parathyroid glands to overwork and produce high amounts of PTH to maintain or restore the calcium level to the standard range. This type of hyperparathyroidism is common in people with chronic kidney disease (CKD) and after certain intestinal surgeries or diseases.

The parathyroid glands are located near the thyroid gland in the neck and are responsible for maintaining the right balance of calcium in the bloodstream and tissues. When the blood calcium levels fall, the parathyroid glands respond by releasing enough PTH to return blood calcium to a normal level. This hormone triggers the release of calcium from bones, increases calcium absorption from the small intestine, and decreases the amount of calcium lost in urine.

In people with kidney disease, the kidneys cannot make active vitamin D, which is needed to absorb calcium. As a result, blood calcium levels drop, and parathyroid hormone levels increase. Chronic kidney failure is the most common cause of secondary hyperparathyroidism.

Secondary hyperparathyroidism can lead to weak bones and calcium buildup in the body, including in the heart and blood vessels. This can increase the risk of bone pain and fractures. Treatment options include drugs, surgery, and controlling blood phosphorus levels.

Frequently asked questions